IL1B and inflammatory bowel disease: A recent study also demonstrated that a subset of IBD patients, non-responsive to anti-TNF, corticosteroid, and anti-integrin therapy, showed significant IL-1β-driven neutrophil interaction with intestinal stromal cells (82).